Effect of Acorus calamus L. Polysaccharide on CD274 and CD326 Expression by Lewis Lung Carcinoma Cells in Mice


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

Tumor cells can maintain their growth via immunosuppression and escape from host antitumor immunity by controlling the PD-1/PD-L1 system. Expression of PD-L1 (CD274) is an inhibitory signal for T cells, while the increase in CD326 expression in the tumor tissue correlates with metastasis development. The experimental preparation on the basis of α(1,2)-L-rhamno-α(1,4)-D-galactopyranosyluronan from Acorus calamus L. produces an antitumor effect: it reduces tumor node size and the number and area of metastases after transplantation of Lewis lung carcinoma. Using flow cytometry, we demonstrated a decrease in the population of tumor cells expressing surface CD274 (PD-L1) and CD326 antigens after 20-day course of α(1,2)-L-rhamno-α(1,4)-D-galactopyranosyluronan.

Авторлар туралы

K. Lopatina

Laboratory of Oncopharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center; Laboratory of Phytochemistry of Siberian Botanical Garden of National Research Tomsk State University

Хат алмасуға жауапты Автор.
Email: k.lopatina@pharmso.ru
Ресей, Tomsk; Tomsk

E. Safonova

Laboratory of Oncopharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: k.lopatina@pharmso.ru
Ресей, Tomsk

K. Nevskaya

Department of Pharmaceutical Analysis, Centre for Introduction of Technologies, Siberian State Medical University, Ministry of Health of the Russian Federation

Email: k.lopatina@pharmso.ru
Ресей, Tomsk

M. Stakheeva

Laboratory of Molecular Oncology and Immunology, Research Institute of Oncology, Tomsk National Research Medical Center

Email: k.lopatina@pharmso.ru
Ресей, Tomsk

A. Gur’ev

Department of Pharmaceutical Analysis, Centre for Introduction of Technologies, Siberian State Medical University, Ministry of Health of the Russian Federation

Email: k.lopatina@pharmso.ru
Ресей, Tomsk

E. Zueva

Laboratory of Oncopharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: k.lopatina@pharmso.ru
Ресей, Tomsk

T. Razina

Laboratory of Oncopharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: k.lopatina@pharmso.ru
Ресей, Tomsk

E. Amosova

Laboratory of Oncopharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: k.lopatina@pharmso.ru
Ресей, Tomsk

S. Krylov

Laboratory of Oncopharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center

Email: k.lopatina@pharmso.ru
Ресей, Tomsk

M. Belousov

Department of Pharmaceutical Analysis, Centre for Introduction of Technologies, Siberian State Medical University, Ministry of Health of the Russian Federation

Email: k.lopatina@pharmso.ru
Ресей, Tomsk


© Springer Science+Business Media, LLC, part of Springer Nature, 2017

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>